Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page
- Check4 days agoChange DetectedThe study record page adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment heading formatting while introducing a new Revision: v3.6.0 label. This reflects a minor editorial update to the page's structure and labeling without changing trial information.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4, indicating a new content revision.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's Revision tag was updated from v3.5.3 to v3.5.4, indicating a minor backend/template update rather than any changes to the study details or user-facing information.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision tag, v3.5.3, has been added to the page, replacing the previous v3.5.2. This reflects a small front-end/system update to the page rendering and metadata surrounding the study details, with no changes to the study content.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.5.0 is now shown in the page footer, replacing the previous label. The prior Revision: v3.4.3 label has been removed.SummaryDifference0.1%

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.